Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

| March 11, 2020

article image
Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: Nearly half of all drug launches underperform revenue expectations. And if that isn’t enough, the outbreak of COVID-19 worldwide is having an effect on how life sciences companies operate their businesses, including how clinical trials are conducted. Most clinical trial research organizations have tried to adapt by tweaking a platform here, adding a new app there, but this has only yielded patchwork systems of sites, spreadsheets and dashboards that further burden the process.

Spotlight

Medicine Agency

Medicine Agency is a consulting and creative services company based in San Francisco that specializes in brand building. We help companies take on new challenges, conquer new markets and bring new ideas for branding and marketing in the digital age. The combined experience of our staff spans the industries that tend to target young, and often affluent, adults. Clients involved in fashion, arts/entertainment, sports (both mainstream and alternative), food/beverage and hi-tech have trusted us for a strong branding strategy that incorporates wisdom from all these traditionally separate worlds.

OTHER ARTICLES

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 20, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?

Article | March 20, 2020

Big pharma stocks have been clobbered during the coronavirus-caused stock market crash. You can count the number of drugmakers with market caps of $25 billion or more whose shares haven't dropped by double-digit percentages on one hand -- and have several fingers left over. Three big pharma stocks have plunged the most: AbbVie (NYSE:ABBV), Bristol Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). But are these stocks smart picks to buy right now?

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | March 20, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

The Future of Pharma Beyond Blockbusters

Article | March 20, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

Spotlight

Medicine Agency

Medicine Agency is a consulting and creative services company based in San Francisco that specializes in brand building. We help companies take on new challenges, conquer new markets and bring new ideas for branding and marketing in the digital age. The combined experience of our staff spans the industries that tend to target young, and often affluent, adults. Clients involved in fashion, arts/entertainment, sports (both mainstream and alternative), food/beverage and hi-tech have trusted us for a strong branding strategy that incorporates wisdom from all these traditionally separate worlds.

Events